

EEG BRAINWAVES SYNCHRONIZATION AND ALPHA BRAINWAVES COMPARISON: STUDY OF PRE AND
POST TREATMENT WITH KENRICO SAP SHEET
Confidential
Property of Kenrico LTD All rights Reserved
Page
3
of
211
Placebo Sap Sheet were made with raw form (non-extract) of wood vinegar, bamboo vinegar,
mushroom chitosan, loquat leaf, houttuynia cordata, mandarin orange, tourmaline, vegetable
fiber and corn flour. As placebo sap sheet were made with raw ingredients, they did not
contain any traces of active ingredients, without sporopollenin and did not have any special
chemical bonding among their active ingredients.
200 participants consist of 95 males and 105 females, ages 21 to 90 with random health
conditions and random stress levels.
To obtain a true randomized result, 50 of the 200 participants were discarded randomly. The
remaining 150 participants were divided into three groups of 50 participants each. The closest
power of 2 (2
n
) with integer 5 as the exponent was selected to obtain the random number for
the three groups. As the final randomized result, 32 (2
5
) participants were assigned to group
one for Site I, 32 (2
5
) participants were assigned to group two for Site II, and 32 (2
5
)
participants were assigned to group three for Site III. Group three is the placebo-controlled
group.
True Randomized Participants
200 participants
95 males and 105 females, ages 21 to
90 with random health conditions and
random stress levels
150 participants
50 of the 200 participants were
discarded randomly
50 participants
Group one
50 participants
Group two
50 participants
Group three
32 final participants
32 (2
5
) participants
were assigned
randomly to group
one for Site I
(experimental group)
32 final participants
32 (2
5
) participants
were assigned
randomly to group
two for Site II
(experimental group)
32 final participants
32 (2
5
) participants
were assigned
randomly to group
three for Site III
(placebo)